Revenue up 4.6% but PBT fell 13% as gross debt jumped 70% to fund capex

What changed

Revenue rose 4.6% to $114.5m despite container volumes falling 7.9% to 254,000 TEU, implying price/mix offset volume weakness. Earnings moved the other way: PBT fell 13.1% to $27.7m and NPAT fell 11.8% to $20.4m, with the effective tax rate broadly stable (26.2% vs 27.2%). Operating cash flow slipped 5.0% to $33.0m. The headline balance-sheet move is funding: gross borrowings rose 70.2% to $131.2m, taking computed net debt to $129.2m from $75.7m, while equity grew 10.5% to $392.0m on an asset base up 17.2% to $562.7m. The final dividend was held at 4.7 cents per share.

What matters

• Earnings quality is deteriorating even as revenue grows. Inflationary cost increases and "investment in capability" absorbed the entire revenue uplift and then some, compressing reported earnings. Underlying NPAT of $18.6m (vs reported $20.4m) fell from $22.0m, so the decline is visible on both measures.
• Leverage stepped up materially. Net debt rose $53.6m in a year in which OCF of $33.0m did not cover capex of $72.1m, leaving pre-lease FCF of negative $39.0m. That gap is structurally smaller than FY21's negative $68.9m only because capex moderated from $103.7m, not because cash generation improved.
• Capital return is no longer covered by internal cash. The flat 4.7cps final dividend represents a 75.0% payout of NPAT (up from 66.1%) and is not covered by pre-lease FCF for the second consecutive year; the shortfall is being funded via drawings.

Expectations

The HY22 shape confirms a second-half-weighted year: H1 delivered 44.3% of full-year revenue and 44.0% of full-year NPAT, implying an H2 revenue of $63.8m and H2 NPAT of $11.4m — a visible recovery from the "challenging first half" characterisation. Management has flagged FY23 guidance for an underlying result from operating activities, but the numeric range is truncated in the supplied excerpt so no target comparison is possible. No multi-year strategic target was provided, so the release can only be judged on its own cash, leverage and margin trajectory, not against a disclosed benchmark.

Quality of result

The result is of mixed quality. Revenue growth into volume weakness looks like real pricing/mix rather than a timing effect, and receivable days were effectively unchanged at 31.7 (vs 31.6), so the top line was not flattered by working capital. However, OCF fell faster than it should have given flat receivables, and cash generation of $33.0m funded less than half of the $72.1m capex programme, with the balance of the investment — and the dividend — funded by a $54.1m increase in borrowings. ROE fell from 6.5% to 5.2%, consistent with an expanding asset base not yet earning. Underlying NPAT of $18.6m sits below reported NPAT of $20.4m, so the "clean" operating read is weaker than the statutory print.

Unresolved

• What specific items reconcile underlying NPAT of $18.6m to reported NPAT of $20.4m? The release references underlying measures but the supplied extract does not include a full reconciliation.
• What is the precise FY23 underlying operating earnings guidance range? The excerpt is truncated at "between $42…".
• How much further capex is required before the investment programme is self-funding, and what is the committed forward capex profile?
• No segment-level revenue/margin disclosure, customer concentration, or bulk-cargo breakdown was supplied, so the composition of the 4.6% revenue gain against a 7.9% container volume decline is not verifiable from this data.

This briefing cannot assess valuation, segment economics, or the detailed composition of underlying earnings adjustments from the supplied materials.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.